SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 144 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $14,304 | -71.8% | 10,919 | -24.8% | 0.00% | – |
Q4 2022 | $50,685 | -20.8% | 14,523 | +19.5% | 0.00% | – |
Q3 2022 | $64,000 | +39.1% | 12,152 | +5.9% | 0.00% | – |
Q2 2022 | $46,000 | -27.0% | 11,480 | +7.5% | 0.00% | – |
Q1 2022 | $63,000 | -36.4% | 10,684 | -15.8% | 0.00% | – |
Q4 2021 | $99,000 | -94.2% | 12,684 | -92.9% | 0.00% | -100.0% |
Q3 2021 | $1,704,000 | -49.6% | 178,353 | -38.1% | 0.00% | -50.0% |
Q2 2021 | $3,381,000 | +10.2% | 288,307 | +5.7% | 0.00% | 0.0% |
Q1 2021 | $3,069,000 | -23.5% | 272,755 | +10.3% | 0.00% | -33.3% |
Q4 2020 | $4,010,000 | +40.5% | 247,347 | -16.0% | 0.00% | +50.0% |
Q3 2020 | $2,855,000 | +1741.9% | 294,469 | +1965.3% | 0.00% | – |
Q2 2020 | $155,000 | +868.8% | 14,258 | +522.9% | 0.00% | – |
Q1 2020 | $16,000 | -88.5% | 2,289 | -86.3% | 0.00% | – |
Q4 2019 | $139,000 | -40.6% | 16,702 | -35.5% | 0.00% | – |
Q3 2019 | $234,000 | +82.8% | 25,881 | +119.1% | 0.00% | – |
Q2 2019 | $128,000 | +509.5% | 11,813 | +438.2% | 0.00% | – |
Q1 2019 | $21,000 | -48.8% | 2,195 | -39.5% | 0.00% | – |
Q4 2018 | $41,000 | -37.9% | 3,627 | -8.7% | 0.00% | – |
Q3 2018 | $66,000 | +17.9% | 3,971 | -0.5% | 0.00% | – |
Q2 2018 | $56,000 | -94.5% | 3,991 | -92.6% | 0.00% | -100.0% |
Q1 2018 | $1,020,000 | +541.5% | 53,638 | +454.2% | 0.00% | – |
Q4 2017 | $159,000 | +30.3% | 9,679 | +19.5% | 0.00% | – |
Q3 2017 | $122,000 | +454.5% | 8,101 | +223.4% | 0.00% | – |
Q2 2017 | $22,000 | +1000.0% | 2,505 | +708.1% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 310 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 310 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -50.0% | 310 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 310 | 0.0% | 0.00% | – |
Q1 2016 | $2,000 | -66.7% | 310 | -53.2% | 0.00% | – |
Q4 2015 | $6,000 | -98.9% | 663 | -98.7% | 0.00% | -100.0% |
Q2 2015 | $556,000 | -40.1% | 50,117 | -15.3% | 0.00% | 0.0% |
Q1 2015 | $928,000 | +32.4% | 59,145 | +28.4% | 0.00% | 0.0% |
Q4 2014 | $701,000 | +28.6% | 46,048 | -9.0% | 0.00% | 0.0% |
Q3 2014 | $545,000 | -41.2% | 50,580 | -16.7% | 0.00% | 0.0% |
Q2 2014 | $927,000 | +18.2% | 60,700 | +40.1% | 0.00% | 0.0% |
Q1 2014 | $784,000 | +53.4% | 43,340 | -11.0% | 0.00% | 0.0% |
Q3 2013 | $511,000 | – | 48,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |